DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Paepegaey AC, Lheure C, Ratour C. et al.
Polyendocrinopathy resulting from pembrolizumab in a patient with a malignant melanoma.
J Endocr Soc 2017;
1: 646-649
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.